BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
March 31, 2003
View Archived Issues
Synta Steps Out Of The Shadows With $75.3M Funding For Pipeline
On its website, Synta Pharmaceuticals Inc. bills itself as the newest 10-year-old pharma firm in Boston. (BioWorld Today)
Read More
Regeneron, Novartis Enter $75M Deal For IL-1 Trap Technology
Read More
Transgenic Mice Generated With Mutant Phosphorylated Synapse Test Retention Of Spatial Memory
Read More
Merck Data On Erbitux Status Appear Positive For ImClone
Read More
Acadia Raises $25M Privately To Advance Multiple Programs
Read More
Antex Filing For Bankruptcy After BioPort Buyout Fizzles
Read More
Procyon Acquiring Pharmacor If It Completes Funding Round
Read More
Other News To Note
Read More
Correction
Read More